Literature DB >> 9616223

Downregulation of T cell receptor expression by CD8(+) lymphocytes in kidney allografts.

R B Mannon1, B L Kotzin, C Nataraj, K Ferri, E Roper, R J Kurlander, T M Coffman.   

Abstract

Allospecific CD8(+) T lymphocytes are an important component of the cellular response in allograft rejection. These cells recognize and engage MHC class I antigens, leading to allospecific cytolytic responses and graft rejection. In mouse kidney allografts that survive to 3 wk after transplantation, we noted that the majority of CD8(+) cells do not express surface alpha/beta T cell receptor alpha/beta(TCR), gamma/deltaTCR, or CD3. However, these CD8(+)TCR- cells did express surface markers characteristic of T cells, including Thy1.2, CD2, and CD5. In addition, the CD8(+)TCR- cells expressed mRNA for TCR Vbeta gene families, and nearly half stained positive for cytoplasmic Vbeta8 protein, suggesting that they are T cells that have downregulated alpha/betaTCR protein expression from their cell surfaces. When these surface TCR- cells were isolated from kidney allografts by flow cytometry and cultured in the presence of either allogeneic or syngeneic stimulators, nearly 100% of cells reacquired normal levels of alpha/betaTCR expression with disproportionate usage of Vbeta8 chains. After recovery of their surface TCR expression, the CD8(+)TCR- population demonstrated strong alloreactivity in culture. These results suggest that the substantial number of CD8(+)TCR- cells found in long-term surviving mouse kidney allografts are alpha/beta-T cells that have downregulated their cell surface expression of TCR. While in other systems this phenotype may identify cells that have engaged antigen, our results indicate that loss of TCR expression by CD8(+) kidney graft-infiltrating cells may not depend on antigen engagement and that elements in the microenvironment of the kidney graft play a key role in this process. Factors that modulate expression of TCR by graft-infiltrating lymphocytes may have an important role in regulating rejection responses.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9616223      PMCID: PMC508841          DOI: 10.1172/JCI1229

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  The intragraft CD8+ T cell response in renal allograft rejection in the mouse.

Authors:  R B Mannon; B L Kotzin; E Roper; C Nataraj; R J Kurlander; T M Coffman
Journal:  Transplantation       Date:  1996-07-15       Impact factor: 4.939

2.  T cell activation determined by T cell receptor number and tunable thresholds.

Authors:  A Viola; A Lanzavecchia
Journal:  Science       Date:  1996-07-05       Impact factor: 47.728

3.  Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection.

Authors:  R J Corry; H J Winn; P S Russell
Journal:  Transplantation       Date:  1973-10       Impact factor: 4.939

4.  Automated colorimetric assay for T cell cytotoxicity.

Authors:  C R Parish; A Müllbacher
Journal:  J Immunol Methods       Date:  1983-03-11       Impact factor: 2.303

5.  Tolerance of T-cell clones is associated with membrane antigen changes.

Authors:  E D Zanders; J R Lamb; M Feldmann; N Green; P C Beverley
Journal:  Nature       Date:  1983 Jun 16-22       Impact factor: 49.962

6.  Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complex.

Authors:  E L Reinherz; S Meuer; K A Fitzgerald; R E Hussey; H Levine; S F Schlossman
Journal:  Cell       Date:  1982-10       Impact factor: 41.582

7.  H2-M3wt-restricted, Listeria monocytogenes-specific CD8 T cells recognize a novel, hydrophobic, protease-resistant, periodate-sensitive antigen.

Authors:  C Nataraj; M L Brown; R M Poston; S M Shawar; R R Rich; K F Lindahl; R J Kurlander
Journal:  Int Immunol       Date:  1996-03       Impact factor: 4.823

8.  Serial triggering of many T-cell receptors by a few peptide-MHC complexes.

Authors:  S Valitutti; S Müller; M Cella; E Padovan; A Lanzavecchia
Journal:  Nature       Date:  1995-05-11       Impact factor: 49.962

9.  Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities.

Authors:  G L Spitalny; E A Havell
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

10.  Kidney transplants in mice. An analysis of the immune status of mice bearing long-term, H-2 incompatible transplants.

Authors:  P S Russell; C M Chase; R B Colvin; J M Plate
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

View more
  5 in total

1.  Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway.

Authors:  C Nataraj; M I Oliverio; R B Mannon; P J Mannon; L P Audoly; C S Amuchastegui; P Ruiz; O Smithies; T M Coffman
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

2.  A novel role for type 1 angiotensin receptors on T lymphocytes to limit target organ damage in hypertension.

Authors:  Jian-dong Zhang; Mehul B Patel; Young-Soo Song; Robert Griffiths; James Burchette; Phillip Ruiz; Matthew A Sparks; Ming Yan; David N Howell; Jose A Gomez; Robert F Spurney; Thomas M Coffman; Steven D Crowley
Journal:  Circ Res       Date:  2012-04-24       Impact factor: 17.367

3.  Most parasite-specific CD8+ cells in Trypanosoma cruzi-infected chronic mice are down-regulated for T-cell receptor-alphabeta and CD8 molecules.

Authors:  M G Grisotto; M R D'Império Lima; C R Marinho; C E Tadokoro; I A Abrahamsohn; J M Alvarez
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

4.  Early acceptance of renal allografts in mice is dependent on foxp3(+) cells.

Authors:  Masahiro Miyajima; Catharine M Chase; Alessandro Alessandrini; Evan A Farkash; Patricia Della Pelle; Gilles Benichou; Jay A Graham; Joren C Madsen; Paul S Russell; Robert B Colvin
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

5.  B lymphocytes differentially influence acute and chronic allograft rejection in mice.

Authors:  David J DiLillo; Robert Griffiths; Surya V Seshan; Cynthia M Magro; Phillip Ruiz; Thomas M Coffman; Thomas F Tedder
Journal:  J Immunol       Date:  2011-01-19       Impact factor: 5.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.